Cargando…

Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation

BACKGROUND: Atrial fibrillation (AF) is associated with myocardial infarction, and patients with AF and no obstructive coronary artery disease can present with symptoms and evidence of cardiac ischemia. We hypothesized that microvascular coronary dysfunction underlies these observations. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijesurendra, Rohan S., Liu, Alexander, Notaristefano, Francesco, Ntusi, Ntobeko A. B., Karamitsos, Theodoros D., Bashir, Yaver, Ginks, Matthew, Rajappan, Kim, Betts, Tim R., Jerosch‐Herold, Michael, Ferreira, Vanessa M., Neubauer, Stefan, Casadei, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201472/
https://www.ncbi.nlm.nih.gov/pubmed/30371239
http://dx.doi.org/10.1161/JAHA.118.009218
_version_ 1783365508586799104
author Wijesurendra, Rohan S.
Liu, Alexander
Notaristefano, Francesco
Ntusi, Ntobeko A. B.
Karamitsos, Theodoros D.
Bashir, Yaver
Ginks, Matthew
Rajappan, Kim
Betts, Tim R.
Jerosch‐Herold, Michael
Ferreira, Vanessa M.
Neubauer, Stefan
Casadei, Barbara
author_facet Wijesurendra, Rohan S.
Liu, Alexander
Notaristefano, Francesco
Ntusi, Ntobeko A. B.
Karamitsos, Theodoros D.
Bashir, Yaver
Ginks, Matthew
Rajappan, Kim
Betts, Tim R.
Jerosch‐Herold, Michael
Ferreira, Vanessa M.
Neubauer, Stefan
Casadei, Barbara
author_sort Wijesurendra, Rohan S.
collection PubMed
description BACKGROUND: Atrial fibrillation (AF) is associated with myocardial infarction, and patients with AF and no obstructive coronary artery disease can present with symptoms and evidence of cardiac ischemia. We hypothesized that microvascular coronary dysfunction underlies these observations. METHODS AND RESULTS: Myocardial blood flow (MBF) at baseline and during adenosine stress and left ventricular and left atrial function were evaluated by magnetic resonance in 49 patients with AF (25 paroxysmal, 24 persistent) with no history of epicardial coronary artery disease or diabetes mellitus, before and 6 to 9 months after ablation. Findings were compared with those obtained in matched controls in sinus rhythm (n=25). Before ablation, patients with AF had impaired left atrial function and left ventricular ejection fraction and strain indices (all P<0.05 versus controls). MBF was impaired in patients both under baseline conditions (1.21±0.24 mL/min per g·[mm Hg·bpm/10(4)](−1) versus 1.34±0.28 mL/min per g·[mm Hg·bpm/10(4)](−1) in controls, P=0.044) and during adenosine stress (2.29±0.48 mL/min per g versus 2.73±0.37 mL/min per g in controls, P<0.001). Under baseline conditions, MBF correlated with left ventricular strain and left atrial function (all P≤0.001), so that cardiac function was most impaired in patients with the lowest MBF. Baseline and stress MBF remained unchanged postablation (both P=ns), and baseline MBF showed similar correlations with functional indices to those present preablation (all P≤0.001). CONCLUSIONS: Baseline and stress MBF are significantly impaired in patients with AF but no epicardial coronary artery disease. Reduction in MBF is proportional to severity of left ventricular and left atrial dysfunction, even after successful ablation. Coronary microvascular dysfunction may be a relevant pathophysiological mechanism in patients with a history of AF.
format Online
Article
Text
id pubmed-6201472
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62014722018-10-31 Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation Wijesurendra, Rohan S. Liu, Alexander Notaristefano, Francesco Ntusi, Ntobeko A. B. Karamitsos, Theodoros D. Bashir, Yaver Ginks, Matthew Rajappan, Kim Betts, Tim R. Jerosch‐Herold, Michael Ferreira, Vanessa M. Neubauer, Stefan Casadei, Barbara J Am Heart Assoc Original Research BACKGROUND: Atrial fibrillation (AF) is associated with myocardial infarction, and patients with AF and no obstructive coronary artery disease can present with symptoms and evidence of cardiac ischemia. We hypothesized that microvascular coronary dysfunction underlies these observations. METHODS AND RESULTS: Myocardial blood flow (MBF) at baseline and during adenosine stress and left ventricular and left atrial function were evaluated by magnetic resonance in 49 patients with AF (25 paroxysmal, 24 persistent) with no history of epicardial coronary artery disease or diabetes mellitus, before and 6 to 9 months after ablation. Findings were compared with those obtained in matched controls in sinus rhythm (n=25). Before ablation, patients with AF had impaired left atrial function and left ventricular ejection fraction and strain indices (all P<0.05 versus controls). MBF was impaired in patients both under baseline conditions (1.21±0.24 mL/min per g·[mm Hg·bpm/10(4)](−1) versus 1.34±0.28 mL/min per g·[mm Hg·bpm/10(4)](−1) in controls, P=0.044) and during adenosine stress (2.29±0.48 mL/min per g versus 2.73±0.37 mL/min per g in controls, P<0.001). Under baseline conditions, MBF correlated with left ventricular strain and left atrial function (all P≤0.001), so that cardiac function was most impaired in patients with the lowest MBF. Baseline and stress MBF remained unchanged postablation (both P=ns), and baseline MBF showed similar correlations with functional indices to those present preablation (all P≤0.001). CONCLUSIONS: Baseline and stress MBF are significantly impaired in patients with AF but no epicardial coronary artery disease. Reduction in MBF is proportional to severity of left ventricular and left atrial dysfunction, even after successful ablation. Coronary microvascular dysfunction may be a relevant pathophysiological mechanism in patients with a history of AF. John Wiley and Sons Inc. 2018-07-27 /pmc/articles/PMC6201472/ /pubmed/30371239 http://dx.doi.org/10.1161/JAHA.118.009218 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Wijesurendra, Rohan S.
Liu, Alexander
Notaristefano, Francesco
Ntusi, Ntobeko A. B.
Karamitsos, Theodoros D.
Bashir, Yaver
Ginks, Matthew
Rajappan, Kim
Betts, Tim R.
Jerosch‐Herold, Michael
Ferreira, Vanessa M.
Neubauer, Stefan
Casadei, Barbara
Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation
title Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation
title_full Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation
title_fullStr Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation
title_full_unstemmed Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation
title_short Myocardial Perfusion Is Impaired and Relates to Cardiac Dysfunction in Patients With Atrial Fibrillation Both Before and After Successful Catheter Ablation
title_sort myocardial perfusion is impaired and relates to cardiac dysfunction in patients with atrial fibrillation both before and after successful catheter ablation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201472/
https://www.ncbi.nlm.nih.gov/pubmed/30371239
http://dx.doi.org/10.1161/JAHA.118.009218
work_keys_str_mv AT wijesurendrarohans myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT liualexander myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT notaristefanofrancesco myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT ntusintobekoab myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT karamitsostheodorosd myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT bashiryaver myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT ginksmatthew myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT rajappankim myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT bettstimr myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT jeroschheroldmichael myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT ferreiravanessam myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT neubauerstefan myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation
AT casadeibarbara myocardialperfusionisimpairedandrelatestocardiacdysfunctioninpatientswithatrialfibrillationbothbeforeandaftersuccessfulcatheterablation